Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

MEDIFAST INC (MED)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow MEDIFAST's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
32.96 +0.49    +1.51%
11:32:56 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 55,949
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 32.47 - 32.99
MEDIFAST 32.96 +0.49 +1.51%

MEDIFAST INC Company Profile

 
Get an in-depth profile of MEDIFAST INC, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryFood & Tobacco
SectorConsumer Non-Cyclicals
Employees

874

Equity Type

ORD

Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.

Contact Information

Address 100 International Drive 18th Floor
Baltimore, 21202
United States
Phone 410 581 8042
Fax -

Top Executives

Name Age Since Title
Jeffrey John Brown 61 2015 Lead Independent Director
Daniel R. Chard 56 2016 Executive Chairman & CEO
Scott D. Schlackman 63 2015 Independent Director
Lawrence J. Cheskin - 2008 Chairman of Scientific Advisory Board
J. Graham Thomas - 2022 Member of Scientific Advisory Board
Nikhil Dhurandhar - 2022 Member of Scientific Advisory Board
Elizabeth Geary 42 2023 Independent Director
Jessica Unick - 2022 Member of Scientific Advisory Board
Michael A. Hoer 68 2018 Independent Director
John E. Hayes - - Member of Scientific Advisory Board
John Paul Foreyt - - Member of Scientific Advisory Board
Sylvia B. Rowe - - Member of Scientific Advisory Board
Mark Messina - - Member of Scientific Advisory Board
George A. Bray - - Member of Scientific Advisory Board
Andrea B. Thomas 58 2019 Independent Director
Ming Xian 60 2018 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MED Comments

Write your thoughts about MEDIFAST INC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Ciprian Gal
Ciprian Gal Mar 14, 2024 11:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
they will beat eps adding already at least 02 from the LFMD investment
Bubble Research
Bubble Research Feb 16, 2024 3:52PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
no support at all, new low day by day
Jens Langman
Jens Langman Nov 10, 2023 10:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Will go up? Financially good numbers, earnings decreasing, performance terrible. Whats going on with medifast? Are the products good?
Ciprian Gal
Ciprian Gal Nov 10, 2023 10:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
all good, they are great quality. no debt. they are also stage 2 of moving to take advantage of the weight drugs. opportunity is key
Ciprian Gal
Ciprian Gal Aug 15, 2023 9:50AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
will they need to invest by buying a teledoc?
Ciprian Gal
Ciprian Gal Aug 15, 2023 9:50AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
they just did invest in life med (lfmd) offering bundle programs, and much more. growth potential plus 15% per anum going forward
Justin Lowery
Justin Lowery Dec 20, 2022 5:50AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Call this the slip and slide cause all it does is take you down for the ride
Mark Meyers
Mark Meyers Aug 18, 2022 5:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
of course "Growing dividend"
Mark Meyers
Mark Meyers Aug 18, 2022 5:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
will RECOVER.Its a great stock with high Groningen dividend.Favorite.
Mark Meyers
Mark Meyers Aug 18, 2022 5:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
of course GROWING dividend.
Ryan Collins
Ryan Collins Aug 04, 2022 11:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why the drop today?
Jens Langman
Jens Langman Aug 04, 2022 11:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Guidance under consensus
Mark Meyers
Mark Meyers Jun 22, 2022 9:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
very high dividend stock.my favorite !!
Yahya onur Altın
Yahya onur Altın Jun 17, 2021 12:35PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Waiting for good entry price
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email